NexgenRx Inc.  

(Public, CVE:NXG)   Watch this stock  
Find more results for David C. Loucks
0.000 (0.00%)
Delayed:   3:36PM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.09 - 0.79
Open     -
Vol / Avg. 0.00/7,281.00
Mkt cap 7.50M
P/E     -
Div/yield     -
EPS -0.01
Shares 55.54M
Beta 0.00
Inst. own     -
Mar 27, 2015
Q4 2014 NexgenRx Inc Earnings Release

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -12.09% -11.33%
Operating margin -12.09% -11.33%
EBITD margin - -8.54%
Return on average assets -68.72% -46.52%
Return on average equity - -
Employees 20 -
CDP Score - -


Suite 600, 185 The West Mall
+1-416-6953393 (Phone)
+1-416-6951635 (Fax)

Website links


NexgenRx Inc. is a Canada-based company, which administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans. The Company earns revenue on the sale of its administration and health benefit claims adjudication services to various organizations who manage health benefit plans on behalf of a number of plan sponsors and to a lesser extent directly to Canadian plan sponsors who wish to provide an Administrative Services Only (ASO) health benefit plan to their plan members. Health benefit claims include drug, dental, extended health and health care spending account claims. This service is sold on a fee-per-transaction basis, in addition to a per member administration fee. It provides claims adjudication services covering three benefit classes; drug, dental and extended health care, plus a healthcare spending account.

Officers and directors

Thomas F. Corcoran Chairman of the Board
Ronald C. Loucks President, Chief Executive Officer, Director
Taba Merrikh Acting Chief Financial Officer
Patrick G. Crowley Director
Age: 1
Barry J. Reiter Director
Ralph Soberano Director
David A. Rosenkrantz Independent Director
F. Gregory Thompson Independent Director